W. Hungerford

发表

Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

Jing Lin, B. D. Cohen, J. Lyssikatos, 2005, Cancer research.

Parallel synthesis enablement of 2-pyridyl-5-cyano-pyrimidine-6-ones—a novel class of HIF-hydroxylase inhibitors

R. Maguire, C. Subramanyam, W. Hungerford, 2010 .

Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.

Daniel P. Walker, A. Kalgutkar, Joel Morris, 2009, Bioorganic & medicinal chemistry letters.

Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus

M. Ammirati, J. Treadway, S. Liras, 2011 .

High-resolution crystal structure and chemical screening reveal pantothenate kinase as a new target for antifungal development.

Choukri Ben Mamoun, Peter C. Gareiss, B. Staker, 2022, Structure.

Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.

Tracey Clark, Matthew D. Wessel, R. D. Connell, 2013, Bioorganic & medicinal chemistry letters.

YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors

P. Glazer, J. Merkel, D. Hoyer, 2015, Molecular Cancer Research.

Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.

J. Gołąb, Firas Fadel, A. Mitschler, 2018, Journal of medicinal chemistry.

Pyrrolocin A, a 3-Decalinoyltetramic Acid with Selective Biological Activity, Isolated from Amazonian Cultures of the Novel Endophyte Diaporthales sp. E6927E

K. Gustafson, S. Strobel, D. Spakowicz, 2015, Natural product communications.

Phosphorylated WNK kinase networks in recoded bacteria recapitulate physiological function

Farren J. Isaacs, Chad J. Miller, A. Levchenko, 2021, Cell reports.

YU 238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-De fi cient Tumors

P. Glazer, J. Merkel, D. Hoyer, 2015 .

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.

L. Pustilnik, S. Bhattacharya, J. Chen, 2007, Bioorganic & medicinal chemistry letters.